Omeros Corp (OMER)
3.535
-0.10
(-2.88%)
USD |
NASDAQ |
May 08, 16:00
3.535
0.00 (0.00%)
After-Hours: 18:59
Omeros Free Cash Flow: 74.30M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | 74.30M |
| September 30, 2023 | 83.85M |
| June 30, 2023 | 90.09M |
| March 31, 2023 | 103.14M |
| December 31, 2022 | -86.60M |
| September 30, 2022 | -79.49M |
| June 30, 2022 | -76.82M |
| March 31, 2022 | -84.93M |
| December 31, 2021 | -110.00M |
| September 30, 2021 | -110.12M |
| June 30, 2021 | -121.37M |
| March 31, 2021 | -131.43M |
| December 31, 2020 | -100.37M |
| September 30, 2020 | -104.99M |
| June 30, 2020 | -77.54M |
| March 31, 2020 | -56.48M |
| December 31, 2019 | -60.41M |
| September 30, 2019 | -62.13M |
| June 30, 2019 | -91.53M |
| March 31, 2019 | -105.96M |
| December 31, 2018 | -104.30M |
| September 30, 2018 | -83.73M |
| June 30, 2018 | -57.99M |
| March 31, 2018 | -35.28M |
| December 31, 2017 | -36.58M |
| Date | Value |
|---|---|
| September 30, 2017 | -43.32M |
| June 30, 2017 | -43.35M |
| March 31, 2017 | -47.78M |
| December 31, 2016 | -51.63M |
| September 30, 2016 | -57.37M |
| June 30, 2016 | -60.77M |
| March 31, 2016 | -64.60M |
| December 31, 2015 | -65.45M |
| September 30, 2015 | -64.50M |
| June 30, 2015 | -65.79M |
| March 31, 2015 | -64.40M |
| December 31, 2014 | -58.07M |
| September 30, 2014 | -42.73M |
| June 30, 2014 | -37.86M |
| March 31, 2014 | -31.99M |
| December 31, 2013 | -29.90M |
| September 30, 2013 | -42.73M |
| June 30, 2013 | -39.13M |
| March 31, 2013 | -38.67M |
| December 31, 2012 | -35.19M |
| September 30, 2012 | -29.40M |
| June 30, 2012 | -26.03M |
| March 31, 2012 | -23.93M |
| December 31, 2011 | -26.91M |
| September 30, 2011 | -20.56M |
Free Cash Flow Range, Past 5 Years
-131.43M
Minimum
Mar 2021
103.14M
Maximum
Mar 2023
-52.78M
Average
-79.49M
Median
Sep 2022
Free Cash Flow Benchmarks
| Ardelyx Inc | -81.12M |
| NovaBay Pharmaceuticals Inc | -4.15M |
| Palatin Technologies Inc | -26.75M |
| iBio Inc | -18.89M |
| Theriva Biologics Inc | -19.20M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -34.82M |
| Cash from Investing (Quarterly) | 116.24M |
| Cash from Financing (Quarterly) | -104.95M |
| Free Cash Flow Per Share (Quarterly) | -0.5597 |
| Free Cash Flow Yield | 33.50% |